CLINICAL & COMMERCIAL STRATEGY ● HEALTHCARE PROFESSIONAL ENGAGEMENT ● REGULATORY & COMPLIANCE GUIDANCE ● TRAINING & EDUCATION
Clover Clinical Solutions is a specialized healthcare consulting firm focused on companies marketing cellular and acellular tissue-based products used in wound management, surgical procedures, and women's health applications.
Helping Tissue-Based Technology Companies
Identify Growth Opportunities & Navigate Complex Healthcare Markets
Drawing on decades of experience spanning clinical practice, sales leadership, national and corporate accounts, and executive clinical affairs leadership, Clover Clinical Solutions bridges the gap between clinical science and commercial execution.
Clover Clinical Solutions helps healthcare, biologic, and tissue organizations identify and capitalize on growth opportunities for tissue-based technologies while navigating the clinical, commercial, reimbursement, and compliance considerations that support responsible commercialization and product adoption.
Helping tissue-based companies identify opportunities others may miss.
What Clover Clinical Solutions Does
Many organizations focus on existing markets while overlooking emerging clinical applications, underserved specialties, educational gaps, and strategic growth opportunities that could significantly expand the impact of their products.
Clover Clinical Solutions was founded on the belief that some of the most valuable opportunities in healthcare are not always the most obvious.
Because the most valuable opportunities are not the most obvious.
Why Clover Clinical Solutions
Leadership
With decades of healthcare experience spanning ICU nursing, sales, national and corporate accounts, and executive Clinical Affairs leadership, Patti Gary, RN, CWCN, Founder and Managing Partner of Clover Clinical Solutions, brings a unique perspective to the clinical, commercial, reimbursement, and compliance challenges surrounding tissue-based technologies and healthcare commercialization.
Her expertise includes wound management, surgical reconstruction, women’s health/urogynecology applications, HCP/KOL engagement, reimbursement strategy, education and training, compliance-focused SOP development, and identification of strategic growth opportunities within complex healthcare markets.
